health-focused activewear

Houston entrepreneur designs clothing that benefits skin health

Emeline Kuhner-Stout, founder of Élastique Athletics, wanted to create a product that was easy to wear and benefitted lymphatic health. Photo courtesy of Élastique Athletics

A few years ago, Emeline Kuhner-Stout, a French ex-pat, was figuring out life as a new mom in a new city. She found her new life in Houston to be sedentary and all consumed with taking care of her baby. Her only time for herself were her daily trips to the gym, and she wanted to make it worth her while.

"There were so many more things I wanted to do for myself, and I just didn't have the time," Kuhner-Stout tells InnovationMap. "It would be so much more efficient if there was a way to combine [elements] to make products that would perform for us."

She noticed at this time that people were starting to care about what they wear to the gym, and she was also looking into the causes of cellulite. Kuhner-Stout and her husband, Myron, who's a patent attorney, started doing some research and found that there weren't any products that existed at the confluence of activewear and skincare.

Élastique Athletics was born to fill that need.

Creating a solution

Photo courtesy of Élastique Athletics

After deciding to tackle cellulite, Kuhner-Stout started doing her homework. She learned that cellulite was caused by poor lymphatic drainage and subsequent water retention.

"We did some research, and found that the best way to improve the appearance of your skin and move those fluids — because the cause [of cellulite] is really about those fluids that get trapped under your skin and cause a lot more negative effects other than skin appearance," Kuhner-Stout says.

She learned that exercise is the best move for improving lymphatic drainage, and another option is to do it manually through massaging and with compression. After around five years of research and development, Kuhner-Stout was able to release her first product for Élastique Athletics — a pair of leggings that have MicroPerle™ micro-massage beads in the compression leggings to massage the skin when worn.

Making space

Photo via instagram.com/elastiqueathletics

The L'Original legging launched online while Kuhner-Stout was working out of WeWork's Jones Building office. She started to realize that customers wanted to try the new type of legging on before they made the $220 investment, and WeWork didn't exactly have the try-on experience Kuhner-Stout wanted for her customers.

She opened the Élastique Athletics store in River Oaks Shopping District late last year and now hopes to use the space to bring women together, and Kuhner-Stout has had health and wellness experts in the space for events and workshops.

"I really want to build Élastique as a true wellness brand, and I think it's very important for us to interact with professionals who focus their energy and time on making women feel great," Kuhner-Stout says.

The new space is also about allowing customers to stay involved with Élastique.

"We want to turn our customers into advocates, and to do that, we have to be more than a product or brand," she says.

Growing her company

Photo courtesy of Élastique Athletics

Kuhner-Stout, who has funded her work by bootstrapping and a family and friends round, hopes to raise a seed round in the near future to continue her growth.

"We feel like we have enough data from our customers to do it right," Kuhner-Stout says on raising a round.

Élastique Athletics is also almost ready to launch its next product — a sports bra that is also optimized with the MicroPerle™ micro-massage bead technology. She also hopes to get her products into more physical spaces.

"These next few months, we are focusing on partnering with high-end spas," Kuhner-Stout says, adding that she wants people to think of her leggings more of a skincare treatment than just activewear.

Trending News

Building Houston

 
 

BiVACOR has received fresh funding from its investors to further develop its artificial heart. Photo courtesy of BiVACOR

A Houston medical device company that is developing an artificial heart announced it has received investment funding to the tune of $18 million.

BiVACOR's investment round was led by Boston-based Cormorant Asset Management and Australia's OneVentures's Healthcare Fund III. According to the company, the funding will be deployed to continue research and development, hiring executives, and support the path to first in human trials.

“We are extremely grateful for the ongoing support from our core investors," says Thomas Vassiliades, who was named CEO of BiVACOR last year, in a news release. "This additional commitment further validates our technology and the need for improved options to treat end-stage biventricular heart failure.

“With this financing, we will be able to double the size of our organization and add key positions from the C-suite to research and development. We are well positioned to advance our preclinical activities and aim to conduct our First in Human early feasibility study planned for the end of the year,” he continues.

Billed as the first long-term treatment for patients with severe biventricular heart failure, the BiVACOR Total Artificial Heart is an implantable artificial heart that utilizes rotary blood pump technology. This technology includes magnetic levitation and is a "durable, reliable, and biocompatible heart replacement," per the company's release. It's about the size of a fist and can be used in a wide range of patients including some children and women and up to adult males.

“Under the leadership of its expert management team, the company has developed a credible strategy for growth as they march toward first in human studies,” says Jeannie Joughin, board chair and principal at One Ventures, in the release. “There is a huge gap in care for patients waiting for a heart transplant, and we are confident that BiVACOR will continue to execute its strategy to swiftly get the Total Artificial Heart into the patients who need it most.”

The company raised its $22 million series B round in early 2021, which was also led by Cormorant Asset Management and OneVentures. To date, BiVACOR has raised $60 million.

“BiVACOR continues to execute on its strategy, and there was no question that we would jump in to lead this funding,” says Bihua Chen, CEO and founder of Cormorant Asset Management. “We are impressed by BiVACOR’s world-class team and continued dedication to push the technology in the clinic. We’re excited to support their growth and vision to transform the treatment of biventricular heart failure with the world’s first fully MAGLEV total artificial heart.”

Founded in 2008, BiVACOR maintains offices in Cerritos, California, and Brisbane, Australia. The company is affiliated with Houston's Texas Heart Institute, where the world's first artificial heart was implanted. BiVACOR's headquarters is at the Texas Medical Center complex.

Trending News